Cover Image
市場調查報告書

全球心臟監測市場 - 成長,趨勢,預測

Global Cardiac Monitoring Market - Segmented by Treatment Type, Diseases, Technology and Geography - Growth, Trends and Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 390864
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球心臟監測市場 - 成長,趨勢,預測 Global Cardiac Monitoring Market - Segmented by Treatment Type, Diseases, Technology and Geography - Growth, Trends and Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 110 Pages
簡介

本報告提供全球心臟監測市場相關調查,彙整市場現狀與未來發展預測,各產品,各地區趨勢,及加入此市場的主要企業簡介等資料。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 主要推論

第5章 市場概要與產業趨勢

  • 目前市場方案
  • 技術概要
  • 治療藥的新開發
  • 投資分析
  • 波特五力分析

第6章 推動市場的要素,阻礙要素,機會,課題分析

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 設備類別
    • 插入型監測設備
    • 心臟輸出監測設備
    • 心電圖
    • 心臟事件記錄器
    • 連續型心電圖監測系統

第8章 各地區趨勢:各地區佔有率與預測

  • 北美市場
  • 歐洲市場
  • 亞太地區市場
  • 中東·非洲市場
  • 南美市場

第9章 競爭環境

  • 新產品上市
  • 協定,聯合,聯盟

第10章 主要供應商

第11章 投資的機會相關分析師預測

第12章 市場未來發展預測

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 26157

The global cardiac monitoring market is expected to register a CAGR of around 4%. North America accounted for the highest market value in 2017. However, Middle East & Africa is expected to register the highest CAGR during the forecast period.

High Worldwide Incidence of Cardiovascular Diseases

Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014.

The other factors boosting the growth of the market studied are - technological advancements, patient awareness, and the increasing number of unmet medical needs in developing and underdeveloped countries.

Risk of Infection Due to Implantable Monitoring Devices

A cardiac implantable device is used by patients who require the continuous monitoring of the heart, for better treatment. Monitoring the cardiac output is a common practice in anesthesia and critical care, but the infections that arise from implanted devices are one of the major restraining factors for the usage of these devices. Infection is always a risk with any invasive procedure and cardiac patients are especially susceptible, as their bodily functions are not running smoothly enough, in the first place. The rising rate of infections due to these devices has tremendous economic implications for hospitals. Patients who were implanted with these monitoring devices are likely to require prolonged hospital stays, and the related costs rack up fairly quickly. However, minimally invasive cardiac output monitors for clinical practice are introduced in the market, without requiring insertion of PAC. These devices utilize different techniques to monitor and each has their own source of potential errors and degree of invasiveness. Therefore, the risk of infection due to implantable medical devices is restraining the growth of the cardiac monitoring market.

North America to Dominate the Market

The volumetric growth of the market studied is significantly high in Asia-Pacific, because of the rising cases of the CVDs and increased purchasing power of the patients in India and China. In North America, sudden cardiac arrest (SCA) is the leading cause of death among the US adults aged 40 years and above. The awareness about these diseases and the availability of various monitoring and therapeutic devices is also increasing, thus accelerating the growth of market. The primary growth driver of the North American cardiac monitoring device market is the rising number of cardiovascular diseases.

Europe has the second largest cardiac monitoring device market. The economic crisis in Europe has slowed down the growth and increased the healthcare costs, while the uneven reimbursement policies across different countries in Europe have brought about limitations in the market.

Major Players - GE HEALTHCARE, PHILIPS HEALTHCARE, SIEMENS HEALTHCARE, TOSHIBA MEDICAL SYSTEMS, MEDTRONIC, CARDIAC SCIENCE CORPORATION, MENNEN MEDICAL, SCHILLER, BOSTON SCIENTIFIC, APPLIED CARDIAC SYSTEM, amongst others.

Reasons to Purchase This Report

Market analysis of the cardiac monitoring market, with region-specific assessments and competition analysis, on global and regional scales

Analyzing various perspectives of the industry with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3 months analyst support along with the Market Estimate sheet (in excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threats of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry Within The Industry

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Rise in the Incidences of Cardiovascular Diseases to Change in Living Pattern
    • 6.1.2 Investments in R&D of Heart Disease Detection
    • 6.1.3 Ease and Use of Portability in Devices
    • 6.1.4 Demand for Home Based, Point of Care & Remote Monitoring Cardiac Systems
  • 6.2 Market Restraints
    • 6.2.1 Risk of Infection due to Implantable Monitoring Devices
    • 6.2.2 Low Level of Accuracy with Invasive Cardiac Output Monitoring Devices
    • 6.2.3 Lack of Skilled Personnel to Operate and Monitor the Devices
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Type
    • 7.1.1 Insertable Cardiac Monitoring Devices
    • 7.1.2 Cardiac Output Monitoring Devices
    • 7.1.3 Electrocardiogram
    • 7.1.4 Cardiac Event Monitoring Systems
    • 7.1.5 Holter Monitoring Systems
  • 7.2 By Geography
    • 7.2.1 North America
      • 7.2.1.1 US
      • 7.2.1.2 Canada
      • 7.2.1.3 Mexico
    • 7.2.2 Europe
      • 7.2.2.1 France
      • 7.2.2.2 Germany
      • 7.2.2.3 UK
      • 7.2.2.4 Italy
      • 7.2.2.5 Spain
      • 7.2.2.6 Rest of Europe (RoE)
    • 7.2.3 Asia-Pacific
      • 7.2.3.1 China
      • 7.2.3.2 Japan
      • 7.2.3.3 India
      • 7.2.3.4 Australia
      • 7.2.3.5 South Korea
      • 7.2.3.6 Rest of Asia-Pacific
    • 7.2.4 Middle East and Africa
      • 7.2.4.1 GCC
      • 7.2.4.2 South Africa
      • 7.2.4.3 Rest of Middle East and Africa
      • 7.2.4.4 South America
      • 7.2.4.5 Brazil
      • 7.2.4.6 Argentina
      • 7.2.4.7 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers and Acquisition Analysis
  • 8.2 Agreements, Collaborations & Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 GE Healthcare
  • 9.2 Phillips Healthcare
  • 9.3 Siemens Healthcare
  • 9.4 Toshiba Medical Systems
  • 9.5 Medtronic
  • 9.6 Cardiac Science Corporation
  • 9.7 Mennen Medical
  • 9.8 Schiller
  • 9.9 Boston Scientific
  • 9.10 Applied Cardiac Systems

10. Future of the Market

Back to Top